CSPC Pharmaceutical Earlier Announced Strategic Research Collaboration, Option, License Agreement With AstraZeneca To Develop Novel Small Nucleic Acid Drug Candidates Using Proprietary SiRNA Drug Discovery And Extrahepatic Targeted Delivery Platforms